Structural basis for the cyclophilin A binding affinity and immunosuppressive potency of E-ISA247 (voclosporin)
2011

Understanding How E-ISA247 Binds to Cyclophilin A

publication Evidence: high

Author Information

Author(s): Andreas Kuglstatter, Francis Mueller, Eric Kusznir, Bernard Gsell, Martine Stihle, Ralf Thoma, Joerg Benz, Launa Aspeslet, Derrick Freitag, Michael Hennig

Primary Institution: F. Hoffmann–La Roche, Discovery Technologies, Basel, Switzerland

Hypothesis

The study investigates the structural basis for the binding affinity and immunosuppressive potency of E-ISA247 compared to its stereoisomer Z-ISA247.

Conclusion

E-ISA247 has a higher binding affinity to cyclophilin A and greater immunosuppressive efficacy than Z-ISA247 and cyclosporin A.

Supporting Evidence

  • E-ISA247 binds to cyclophilin A with a dissociation constant of 15 nM.
  • Z-ISA247 has a higher dissociation constant of 61 nM, indicating weaker binding.
  • The structural differences between E-ISA247 and Z-ISA247 affect their immunosuppressive efficacy.

Takeaway

E-ISA247 is a drug that works better than its sister drug Z-ISA247 because it fits better with a protein in our body that helps control the immune system.

Methodology

X-ray crystal structures of E-ISA247 and Z-ISA247 bound to cyclophilin A were determined, and their binding affinities were measured using fluorescence spectroscopy.

Digital Object Identifier (DOI)

10.1107/S0907444910051905

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication